²é¿´: 786  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

ºÎÐñ

½ð³æ (СÓÐÃûÆø)

[ÇóÖú] ÇóÖúÒ»¸öÖÐÎÄÕªÒªµÄÓ¢ÎÄ·­Ò룬лл£¡

лл³æ×ÓÃǵIJÎÓ룬×ÛÊöÈçÏ£¡
[ÕªÒª] Ä¿µÄ£ºÌ½ÌÖÃÀÖÞ´óó¹ÌáÈ¡Îï¶ÔºÉÁöСÊóS180ÈâÁöµÄÒÖÖÆ×÷ÓÃÒÔ¼°¿¹Ö×ÁöÃâÒßЧӦ»úÖÆ¡£·½·¨£ºÓÒǰ֫ҸϽÓÖÖS180ϸ°ûµÄÀ¥Ã÷ÖÖСÊó£¬Á¬Ðø¹àθÃÀÖÞ´óó¹ÌáÈ¡ÎïC¢ò-3[50¡¢100¡¢200mg/(kg.d)]10Ì죬¹Û²ìC¢ò-3¶ÔS180ÈâÁöµÄÉú³¤×÷Ó㬳ÆÁ¿Ð¡ÊóÃâÒ߯÷¹Ù¼ÆËãÔàÆ÷Ö¸Êý£» Ó¦ÓÃELISAÊÔ¼ÁºÐ¼ì²âСÊóѪÇåÖÐѪ¹ÜÄÚÆ¤Éú³¤Òò×Ó(VEGF)ºÍÖ×Áö»µËÀÒò×Ó-¦Á(TNF-¦Á)µÄº¬Á¿¡£½á¹û£ºÃÀÖÞ´óó¹ÌáÈ¡Îï¶ÔСÊóS180ÈâÁöµÄÉú³¤¾ßÓÐÃ÷ÏÔµÄÒÖÖÆ×÷Óã¬ÃÀÖÞ´óó¹ÌáÈ¡Îï¸ß¡¢ÖС¢µÍ¼ÁÁ¿×éµÄÒÖÁöÂÊ·Ö±ðΪ58.22%¡¢45.66%¡¢35.37%£»ÃÀÖÞ´óó¹ÌáÈ¡Îï¶ÔСÊóµÄÃâÒ߯÷¹Ù¾ßÓб£»¤×÷Ó㻲¢ÄÜÃ÷ÏÔÌá¸ßСÊóѪÇåÖÐVEGFºÍTNF-¦ÁµÄº¬Á¿¡£½áÂÛ£ºÃÀÖÞ´óó¹ÌáÈ¡ÎïÄÜÃ÷ÏÔÒÖÖÆÐ¡ÊóS180ÈâÁöµÄÉú³¤£¬Ìá¸ßѪÇåÖÐVEGFºÍTNF-¦ÁµÄˮƽ¿ÉÄÜÊÇÆä·¢»Ó¿¹Ö×Áö×÷ÓõÄ;¾¶¡£

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

fjtony163

°æÖ÷ (ÎÄ̳¾«Ó¢)

Ã×Ã×

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï
°®ÓëÓêÏÂ(½ð±Ò+2): 2011-10-23 17:09:24
ºÎÐñ(½ð±Ò+50, ·­ÒëEPI+1): ºÇºÇ£¬ÎÒÒªÀ­¶¡Îĵģ¬Ð»Ð»ÄãÁËŶ 2011-10-24 08:56:25
Abstract:
Objective: research on extractive of Americana Linn£¨Periplaneta americana£©inhibition function on tumor-bearing rats S180 sarcoma and anti-cancer immune mechanism.
Methods: vaccinate KM rats with S180 cells on right fore oxter and continuously lavage the extractive of American Linn CII-3[50¡¢100¡¢200mg/(kg.d)] for 10 days. Observe the growth effect on S180 tumor by CII-3 and weigh rats immune organs to calculate the index of visceral organs. Use ELISA kit to test the concentration of vessel endothelium growth factor (VEGF) and tumor necrosis factor-¦Á (TNF-¦Á) in serum.
Results: The extractive of American Linn had apparent inhibition effect on growth of S180 tumor. The tumor inhibition ratio of high, medium, and low dosage groups are 58.22%, 45.66%, and 35.37%. The extractive has protective function on rats immune organs and dramatically increases the concentration of VEGF and TNF-¦Á in serum.
Conclusions: The extractive of American Linn can inhibit the growth of rats S180 tumor and the ways to resist tumor cells may be increasing concentrations of VEGF and TNF-¦Á in serum.

ÄǸöÃÀÖÞ´óó¹ÓÐÓ¢ÓïºÍÀ­¶¡Á½ÖÖ·­Ò룬¿´LZ×Ô¼ºÐèÒªÄÄÖÖÁË¡£
2Â¥2011-10-23 11:42:52
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ºÎÐñ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Çóµ÷¼Á +3 QiMing7 2026-03-25 3/150 2026-03-25 21:13 by ¸øÄãÄã×¢ÒâÐÝÏ¢
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤304ÇóBÇøµ÷¼Á +3 Çñgl 2026-03-25 3/150 2026-03-25 19:03 by Ainin_
[¿¼ÑÐ] ¸÷λÀÏʦÄúºÃ£º±¾È˳õÊÔ372·Ö +5 jjÓ¿77 2026-03-25 6/300 2026-03-25 14:15 by mapenggao
[¿¼ÑÐ] 281Çóµ÷¼Á +4 Koxui 2026-03-24 5/250 2026-03-25 11:38 by userper
[¿¼ÑÐ] 289Çóµ÷¼Á +9 »³èªÎÕè¤l 2026-03-20 9/450 2026-03-25 11:02 by userper
[¿¼ÑÐ] 278Çóµ÷¼Á +4 ÎÒ¿ÉÒÔÉϰ¶µÄ¶Ô 2026-03-19 4/200 2026-03-25 11:01 by userper
[¿¼ÑÐ] 300·Ö£¬²ÄÁÏ£¬Çóµ÷¼Á£¬Ó¢Ò»Êý¶þ +5 ³¬ÔÞµÄ 2026-03-24 5/250 2026-03-24 21:07 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á£¬Çóµ¼Ê¦ÊÕ +7 ÌìÌìºÃÔËÀ´Éϰ¶° 2026-03-24 7/350 2026-03-24 20:26 by peike
[¿¼ÑÐ] 307Çóµ÷¼Á +3 ÓàÒâÇä 2026-03-21 6/300 2026-03-24 15:03 by ÓàÒâÇä
[¿¼ÑÐ] ¡¾Ë«Ò»Á÷ԺУÐÂÄÜÔ´¡¢»·¾³²ÄÁÏ£¬²ÄÁϼӹ¤ÓëÄ£ÄâÕÐÊÕ´óÁ¿µ÷¼Á¡¿ +4 Higraduate 2026-03-22 7/350 2026-03-24 11:23 by ÖÖ´óÊ÷
[¿¼ÑÐ] 384Çóµ÷¼Á +3 ×Óϵ²© 2026-03-22 6/300 2026-03-23 21:45 by ×Óϵ²©
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí²ÄÁϹ¤³Ì348Çóµ÷¼Á +6 £þ^£þ©bº¹ 2026-03-19 9/450 2026-03-23 19:53 by pswait
[¿¼ÑÐ] 263Çóµ÷¼Á +6 yqdszhdap£­ 2026-03-22 9/450 2026-03-23 12:57 by yqdszhdap£­
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬×Ü·Ö320Çóµ÷¼Á +5 À§À§À§À§À¤À¤ 2026-03-20 6/300 2026-03-22 17:41 by hxsm
[¿¼ÑÐ] 306Çóµ÷¼Á +5 À´ºÃÔËÀ´À´À´ 2026-03-22 5/250 2026-03-22 16:17 by BruceLiu320
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ070300 ѧ˶336Çóµ÷¼Á +5 vvÃÔ 2026-03-21 8/400 2026-03-22 14:20 by ColorlessPI
[¿¼ÑÐ] Çóµ÷¼Á +7 Auroracx 2026-03-22 7/350 2026-03-22 12:38 by ËØÑÕÇã³Ç1988
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤£¨0856£©304Çó BÇø µ÷¼Á +3 Çñgl 2026-03-21 3/150 2026-03-21 13:47 by lature00
[¿¼ÑÐ] ÖÐÄÏ´óѧ»¯Ñ§Ñ§Ë¶337Çóµ÷¼Á +3 niko- 2026-03-19 6/300 2026-03-20 21:58 by luoyongfeng
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷ÄϽ»Í¨ ר˶ ²ÄÁÏ355 ±¾¿ÆË«·Ç Çóµ÷¼Á +5 Î÷ÄϽ»Í¨×¨²Ä355 2026-03-19 5/250 2026-03-20 21:10 by JourneyLucky
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û